Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Mukthinuthalapati Mathrusri Annapurna"'
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 7:39-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae1107f0ef94f750d33a7f81393baf7
https://doi.org/10.31080/asps.2023.07.0952
https://doi.org/10.31080/asps.2023.07.0952
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 7:33-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9777ff4c62fcde052370d009e41ac07
https://doi.org/10.31080/asps.2023.07.0951
https://doi.org/10.31080/asps.2023.07.0951
Autor:
BUKKAPATNAM, V.1 venki.b11@gmail.com, MUKTHINUTHALAPATI, MATHRUSRI ANNAPURNA1, ROUTHU, K. C.1
Publikováno v:
Indian Journal of Pharmaceutical Sciences. Jul/Aug2022, Vol. 84 Issue 4, p300-310. 11p.
Publikováno v:
Research Journal of Pharmacy and Technology. :1484-1490
Valsartan is an orally active antihypertensive agent which belongs to the category of angiotensin II type I receptor antagonists. Valsartan is used for the treatment of heart failure, hypertension, myocardial infraction and diabetic nephropathy. A ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd474e1f6be83e7345e161f8f2369fe4
https://doi.org/10.52711/0974-360x.2023.00244
https://doi.org/10.52711/0974-360x.2023.00244
Publikováno v:
Research Journal of Pharmacy and Technology. :5700-5706
Favipiravir is an anti-viral agent used for the treatment of a large number of RNA viruses including influenza and was considered for the treatment of COVID-19. A new stability indicating RP-HPLC has been developed for the estimation of Favipiravir a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89dc44102fcae3d27a562418eec66f9d
https://doi.org/10.52711/0974-360x.2022.00961
https://doi.org/10.52711/0974-360x.2022.00961
Publikováno v:
Acta Scientific Pharmaceutical Sciences. :86-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f8d28d9171f510f2bfee10fd970e7ac
https://doi.org/10.31080/asps.2022.06.0920
https://doi.org/10.31080/asps.2022.06.0920
Publikováno v:
Acta Scientific Pharmaceutical Sciences. :25-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cf14bee2eb97c2cf49643f32f1b2b20
https://doi.org/10.31080/asps.2022.06.0912
https://doi.org/10.31080/asps.2022.06.0912
Publikováno v:
Acta Scientific Pharmaceutical Sciences. :77-85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8ae470a62e7dd85854faa5fd4992be0
https://doi.org/10.31080/asps.2022.06.0919
https://doi.org/10.31080/asps.2022.06.0919
Publikováno v:
Acta Scientific Pharmaceutical Sciences. :68-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e9c25260785878bb8dc8cae475f8166
https://doi.org/10.31080/asps.2022.06.0918
https://doi.org/10.31080/asps.2022.06.0918
Publikováno v:
Acta Scientific Pharmaceutical Sciences. :03-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::506aefc3bf308d27721f8ee8b67daa1e
https://doi.org/10.31080/asps.2022.06.0902
https://doi.org/10.31080/asps.2022.06.0902